Farzin Fath‐Ordoubadi

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan et al. · European Heart Journal · 2017 · 295 citations · Full text

Medicine, Cardiology, Surgery +17

A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control

Valérie Decraene, Hang Phan, Ryan George et al. · Antimicrobial Agents and Chemotherapy · 2018 · 147 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms

Paul D. Williams, Mamas A. Mamas, Kenneth Morgan et al. · EuroIntervention · 2012 · 139 citations

Medicine, Cardiology, Interventional Cardiology +9

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak et al. · JACC: Cardiovascular Interventions · 2019 · 113 citations

Medicine, Cardiology, Clinical Sciences +17